First granular pediatric-specific adrenal insufficiency treatment ever

ALKINDI SPRINKLE granules are the only G-rated hydrocortisone treatment that allows for more accurate and individualized dosing in infants, children, and adolescents (neonate to <17 years old) with adrenal insufficiency (AI), including congenital adrenal hyperplasia (CAH).1,2*

ALKINDI SPRINKLE Patient Referral Form icon

Prescribing ALKINDI SPRINKLE

All prescriptions for ALKINDI SPRINKLE need to be sent directly to Anovo® Specialty Pharmacy, using either of the methods below. Once ALKINDI SPRINKLE has been prescribed, your patient will have access to Eton Cares, a comprehensive patient support program.

Fax prescription icon

Via Fax

  • Complete the ALKINDI SPRINKLE Patient Referral Form, which captures your prescription details and important information for the benefits investigation process
  • Send via fax (1-855-813-2039) to Anovo Specialty Pharmacy
Download form
e-Script icon

Via e-Script

  • Initiate e-Script from EMR system
  • Select "Anovo #5" for pharmacy

Anovo will follow up with a call to your office to gather the patient information required for the benefits investigation process.

All about pediatric AI

Use these downloadable resources to stay up to date on your young patient's
condition—from the basics of AI to the importance of cortisol in the body.

EMR=electronic medical record; IFU=instructions for use.

*The safety and effectiveness of ALKINDI SPRINKLE have not been established in patients over 17 years of age.1

References:

  • ALKINDI SPRINKLE. Package insert. Eton Pharmaceuticals, Inc; 2021.
  • Whitaker MJ, Spielmann S, Digweed D, et al. Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency. J Clin Endocrinol Metab. 2015;100(4):1681-1688. doi:10.1210/jc.2014-4060. 
  • Porter J, Blair J, Ross RJ. Is physiological glucocorticoid replacement important in children? Arch Dis Child. 2017;102(2):199-205. doi:10.1136/archdischild-2015-309538.
  • Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. doi:10.1210/jc.2015-1710.

Be the first to know

Sign up to receive the latest updates and information about ALKINDI SPRINKLE.

Eton Pharmaceuticals logo

This site is for US audiences only. © 2021 Eton Pharmaceuticals. All rights reserved. Eton, ALKINDI SPRINKLE, and Eton Cares are trademarks of Eton Pharmaceuticals. All other trademarks are property of their respective owners. WS-ALK-001-rev3-04/21